Cargando…
Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review
Anaplastic lymphoma kinase gene (ALK) rearrangement is present in only approximately 5% of non-small cell lung cancers (NSCLCs) and is scarce in LCNEC patients. The conventional first-line treatment options are chemotherapy combined with immunotherapy or chemotherapy followed by palliative radiother...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646488/ https://www.ncbi.nlm.nih.gov/pubmed/38023218 http://dx.doi.org/10.3389/fonc.2023.1227980 |